Literature DB >> 31101454

Drug-Target Association Kinetics in Drug Discovery.

Adriaan P IJzerman1, Dong Guo2.   

Abstract

The important role of ligand-receptor binding kinetics in drug design and discovery is increasingly recognized by the drug research community. Over the past decade, accumulating evidence has shown that optimizing the ligand's dissociation rate constant can lead to desirable duration of in vivo target occupancy and, hence, improved pharmacodynamic properties. However, the association rate constant as a pharmacological principle remains less investigated, whereas it can play an equally important role in the selection of drug candidates. This review provides a compilation and discussion of otherwise scarce and dispersed information on this topic, bringing to light the importance of drug-target association in kinetics-directed drug design and discovery.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  association rate constant; binding kinetics; duration of drug action; onset of drug action; target occupancy

Year:  2019        PMID: 31101454     DOI: 10.1016/j.tibs.2019.04.004

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  10 in total

1.  Exploring the kinetic selectivity of drugs targeting the β1 -adrenoceptor.

Authors:  David A Sykes; Mireia Jiménez-Rosés; John Reilly; Robin A Fairhurst; Steven J Charlton; Dmitry B Veprintsev
Journal:  Pharmacol Res Perspect       Date:  2022-08

2.  Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists.

Authors:  Anna Vlachodimou; Henk de Vries; Milena Pasoli; Miranda Goudswaard; Soon-Ai Kim; Yong-Chul Kim; Mirko Scortichini; Melissa Marshall; Joel Linden; Laura H Heitman; Kenneth A Jacobson; Adriaan P IJzerman
Journal:  Biochem Pharmacol       Date:  2022-04-06       Impact factor: 6.100

3.  The feasibility of determining kinetic constants from isothermal titration calorimetry data.

Authors:  Shih-Chia Tso; Thomas A Jowitt; Chad A Brautigam
Journal:  Biophys J       Date:  2022-04-30       Impact factor: 3.699

4.  Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.

Authors:  Yong Ai; Lucia Hwang; Alexander D MacKerell; Ari Melnick; Fengtian Xue
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

Review 5.  Tuning up Transcription Factors for Therapy.

Authors:  Attila Becskei
Journal:  Molecules       Date:  2020-04-20       Impact factor: 4.411

Review 6.  Deep learning tools for advancing drug discovery and development.

Authors:  Sagorika Nag; Anurag T K Baidya; Abhimanyu Mandal; Alen T Mathew; Bhanuranjan Das; Bharti Devi; Rajnish Kumar
Journal:  3 Biotech       Date:  2022-04-09       Impact factor: 2.893

7.  A Scintillation Proximity Assay for Real-Time Kinetic Analysis of Chemokine-Chemokine Receptor Interactions.

Authors:  Stefanie Alexandra Eberle; Martin Gustavsson
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

8.  A multidimensional metabolomics workflow to image biodistribution and evaluate pharmacodynamics in adult zebrafish.

Authors:  Madelyn M Jackstadt; Casey A Chamberlain; Steven R Doonan; Leah P Shriver; Gary J Patti
Journal:  Dis Model Mech       Date:  2022-08-16       Impact factor: 5.732

9.  Predicting the mutation effects of protein-ligand interactions via end-point binding free energy calculations: strategies and analyses.

Authors:  Yang Yu; Zhe Wang; Lingling Wang; Sheng Tian; Tingjun Hou; Huiyong Sun
Journal:  J Cheminform       Date:  2022-08-20       Impact factor: 8.489

Review 10.  Bioresponsive Polymers for Nanomedicine-Expectations and Reality!

Authors:  Sabina Quader; Joachim F R Van Guyse
Journal:  Polymers (Basel)       Date:  2022-09-03       Impact factor: 4.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.